Evidence map›Paper›PMID 37887611›Full record

ArticleBiomimetics (Basel, Switzerland)2023

YOLOv5-MS: Real-Time Multi-Surveillance Pedestrian Target Detection Model for Smart Cities.

Fangzheng Song, Peng Li

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Bioinspired Artificial Intelligence Applications 2023.Biomimetics (Basel, Switzerland) · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fangzheng SongCollege of Information Science and Engineering, Henan University of Technology, Zhengzhou 450001, China.
Peng LiBeijing Institute of Technology, Beijing 100081, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intelligent video surveillance plays a pivotal role in enhancing the infrastructure of smart urban environments. The seamless integration of multi-angled cameras, functioning as perceptive sensors, significantly enhances pedestrian detection and augments security measures in smart cities. Nevertheless, current pedestrian-focused target detection encounters challenges such as slow detection speeds and increased costs. To address these challenges, we introduce the YOLOv5-MS model, an YOLOv5-based solution for target detection. Initially, we optimize the multi-threaded acquisition of video streams within YOLOv5 to ensure image stability and real-time performance. Subsequently, leveraging reparameterization, we replace the original BackBone convolution with RepvggBlock, streamlining the model by reducing convolutional layer channels, thereby enhancing the inference speed. Additionally, the incorporation of a bioinspired "squeeze and excitation" module in the convolutional neural network significantly enhances the detection accuracy. This module improves target focusing and diminishes the influence of irrelevant elements. Furthermore, the integration of the K-means algorithm and bioinspired Retinex image augmentation during training effectively enhances the model's detection efficacy. Finally, loss computation adopts the Focal-EIOU approach. The empirical findings from our internally developed smart city dataset unveil YOLOv5-MS's impressive 96.5% mAP value, indicating a significant 2.0% advancement over YOLOv5s. Moreover, the average inference speed demonstrates a notable 21.3% increase. These data decisively substantiate the model's superiority, showcasing its capacity to effectively perform pedestrian detection within an Intranet of over 50 video surveillance cameras, in harmony with our stringent requisites.

Indexed as

image augmentationIoU lossmulti-surveillanceSE modelsmart cityYOLOv5-MS

Identifiers

PMID37887611
PMCPMC10604626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.